MoonLake Immunotherapeutics
MLTX
MLTX
33 hedge funds and large institutions have $396M invested in MoonLake Immunotherapeutics in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+9
Holders Change %
+37.5%
% of All Funds
0.53%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
6
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MWM
26
Meridian Wealth Management
Lexington,
Kentucky
| $154K | -$123K | -12,000 | -44% |
|
|
VF
27
Virtu Financial
New York
| $151K | +$151K | +14,395 | New |
|
28
Two Sigma Investments
New York
| $130K | +$130K | +12,385 | New |
|
29
Renaissance Technologies
New York
| $122K | +$122K | +11,609 | New |
|
30
Geode Capital Management
Boston,
Massachusetts
| $120K | +$120K | +11,451 | New |
|
31
Goldman Sachs
New York
| $106K | -$1.05K | -100 | -1% |
|
32
Bank of America
Charlotte,
North Carolina
| $83K | +$83K | +7,900 | New |
|
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$1K | +76 | New |
|
34
Point72 Asset Management
Stamford,
Connecticut
| – | -$2.6M | -335,000 | Closed |
|
|
GTC
35
Ghost Tree Capital
New York
| – | -$2.33M | -300,000 | Closed |
|
|
MIM
36
Monashee Investment Management
Boston,
Massachusetts
| – | -$1.49M | -191,945 | Closed |
|
|
AA
37
ALPS Advisors
Denver,
Colorado
| – | -$160K | -20,144 | Closed |
|